Home›Research›Compare›GLP-2 vs KPV
Peptide ComparisonGLP-2 vs KPV
Both are Tissue Repair peptides.
GLP-2
Glucagon-like Peptide-2
11 providers listed
KPV
Lys-Pro-Val
Half-life: Short (minutes to hours)
102 providers listed
GLP-2 is FDA-approved, while KPV is nomination withdrawn — the clearest structural difference between them.
GLP-2
Evidence
KPV
Evidence
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | GLP-2 |
| Further along in FDA review | GLP-2 |
| Oral administration option | KPV |
| Lower typical price per mg | KPV |
| More provider options (11 vs 102) | KPV |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
GLP-2
KPV
GLP-2
Prostaglandin E2 stimulates GLP-1 and GLP-2 secretion and reduces glucose absorption in the perfused rat smal…
The Role of Vasoactive Intestinal Peptide in Glucagon-like Peptide-2-Mediated Intestinal Lipid Handling.
PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.
Early ecological changes in intestinal microbiota with the long-acting GLP-2 analog apraglutide in short bowe…
+4 more
KPV
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the P…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
+2 more
About GLP-2
Binds GLP-2 receptor on intestinal enteroendocrine cells. Promotes enterocyte proliferation and reduces apoptosis, increasing villus height and crypt depth. Strengthens tight junctions and reduces intestinal permeability.
About KPV
Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
GLP-2
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
KPV
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
GLP-2
KPV
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). GLP-2 vs KPV — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/glp-2/kpv